PremiumThe FlyVivani Medical announces anticipated upcoming milestones Vivani Medical to focus on developing NPM-115, NPM-139, emerging pipeline Vivani Medical reports Q4 EPS (11c) vs. (12c) last year PremiumPre-EarningsVANI Earnings this Week: How Will it Perform? Vivani Medical’s Innovative Drug Delivery Platform and Promising Developments Earn Buy Rating Vivani Medical Advances with LIBERATE-1 Clinical Trial PremiumCompany AnnouncementsVivani Medical Secures Funding for GLP-1 Implant Trial VANI Upcoming Earnings Report: What to Expect? JPMorgan, Five Below downgraded: Wall Street’s top analyst calls
